These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21471240)

  • 1. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon.
    Marshall HD; Urban SL; Welsh RM
    J Virol; 2011 Jun; 85(12):5929-39. PubMed ID: 21471240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation.
    Kim SK; Brehm MA; Welsh RM; Selin LK
    J Immunol; 2002 Jul; 169(1):90-8. PubMed ID: 12077233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of bystander T cell proliferation by viruses and type I interferon in vivo.
    Tough DF; Borrow P; Sprent J
    Science; 1996 Jun; 272(5270):1947-50. PubMed ID: 8658169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions.
    Marshall HD; Prince AL; Berg LJ; Welsh RM
    J Immunol; 2010 Aug; 185(3):1419-28. PubMed ID: 20592282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.
    Zarozinski CC; McNally JM; Lohman BL; Daniels KA; Welsh RM
    J Virol; 2000 Apr; 74(8):3650-8. PubMed ID: 10729141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC basis of T cell-dependent heterologous immunity to arenaviruses.
    Daniels KA; Hatfield SD; Welsh RM; Brehm MA
    Virology; 2014 Sep; 464-465():213-217. PubMed ID: 25094042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
    Selin LK; Vergilis K; Welsh RM; Nahill SR
    J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.
    Kolumam GA; Thomas S; Thompson LJ; Sprent J; Murali-Krishna K
    J Exp Med; 2005 Sep; 202(5):637-50. PubMed ID: 16129706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.
    Urban SL; Welsh RM
    PLoS Pathog; 2014 Sep; 10(9):e1004357. PubMed ID: 25255454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin.
    Grujic M; Christensen JP; Sørensen MR; Abrink M; Pejler G; Thomsen AR
    J Immunol; 2008 Jul; 181(2):1043-51. PubMed ID: 18606656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
    Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
    J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensing and alarm function of resident memory CD8⁺ T cells.
    Schenkel JM; Fraser KA; Vezys V; Masopust D
    Nat Immunol; 2013 May; 14(5):509-13. PubMed ID: 23542740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses.
    Keppler SJ; Rosenits K; Koegl T; Vucikuja S; Aichele P
    PLoS One; 2012; 7(7):e40865. PubMed ID: 22815848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
    Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
    J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.
    Flatz L; Hegazy AN; Bergthaler A; Verschoor A; Claus C; Fernandez M; Gattinoni L; Johnson S; Kreppel F; Kochanek S; Broek Mv; Radbruch A; Lévy F; Lambert PH; Siegrist CA; Restifo NP; Löhning M; Ochsenbein AF; Nabel GJ; Pinschewer DD
    Nat Med; 2010 Mar; 16(3):339-45. PubMed ID: 20139992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.